Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis - PubMed (original) (raw)

Clinical Trial

. 2009 Nov;15(11):1617-8.

doi: 10.1002/ibd.20861.

• PMID: 19161180
• DOI: 10.1002/ibd.20861

Clinical Trial

Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis

Yasuhiro Takeda et al. Inflamm Bowel Dis. 2009 Nov.

No abstract available

PubMed Disclaimer

Similar articles

• Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial.
  Tamaki H, Nakase H, Inoue S, Kawanami C, Itani T, Ohana M, Kusaka T, Uose S, Hisatsune H, Tojo M, Noda T, Arasawa S, Izuta M, Kubo A, Ogawa C, Matsunaka T, Shibatouge M. Tamaki H, et al. Dig Endosc. 2016 Jan;28(1):67-74. doi: 10.1111/den.12553. Epub 2015 Nov 2. Dig Endosc. 2016. PMID: 26418574 Clinical Trial.
• Synbiotic therapy: a promising new adjunctive therapy for ulcerative colitis.
  Haskey N, Dahl WJ. Haskey N, et al. Nutr Rev. 2006 Mar;64(3):132-8. doi: 10.1111/j.1753-4887.2006.tb00196.x. Nutr Rev. 2006. PMID: 16572600 Review.
• Probiotics in spondyloarthropathy associated with ulcerative colitis: a pilot study.
  Sanges M, Valente G, Rea M, Della Gatta R, De Franchis G, Sollazzo R, D'Arienzo A. Sanges M, et al. Eur Rev Med Pharmacol Sci. 2009 May-Jun;13(3):233-4. Eur Rev Med Pharmacol Sci. 2009. PMID: 19673175 Clinical Trial. No abstract available.
• Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis.
  Bai AP, Ouyang Q, Xiao XR, Li SF. Bai AP, et al. Int J Clin Pract. 2006 Mar;60(3):284-8. doi: 10.1111/j.1368-5031.2006.00833.x. Int J Clin Pract. 2006. PMID: 16494642 Clinical Trial.
• [Probiotics in chronic inflammatory bowel disease].
  Böhm S, Kruis W. Böhm S, et al. MMW Fortschr Med. 2006 Aug 31;148(35-36):30-4. MMW Fortschr Med. 2006. PMID: 16995360 Review. German.

Cited by

• Evaluation of Porcine Intestinal Epitheliocytes as an In vitro Immunoassay System for the Selection of Probiotic Bifidobacteria to Alleviate Inflammatory Bowel Disease.
  Sato N, Yuzawa M, Aminul MI, Tomokiyo M, Albarracin L, Garcia-Castillo V, Ideka-Ohtsubo W, Iwabuchi N, Xiao JZ, Garcia-Cancino A, Villena J, Kitazawa H. Sato N, et al. Probiotics Antimicrob Proteins. 2021 Jun;13(3):824-836. doi: 10.1007/s12602-020-09694-z. Probiotics Antimicrob Proteins. 2021. PMID: 32779098
• Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives.
  Abdulqadir R, Engers J, Al-Sadi R. Abdulqadir R, et al. Curr Dev Nutr. 2023 Oct 30;7(12):102026. doi: 10.1016/j.cdnut.2023.102026. eCollection 2023 Dec. Curr Dev Nutr. 2023. PMID: 38076401 Free PMC article. Review.
• Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches.
  Štofilová J, Kvaková M, Kamlárová A, Hijová E, Bertková I, Guľašová Z. Štofilová J, et al. Biomedicines. 2022 Sep 9;10(9):2236. doi: 10.3390/biomedicines10092236. Biomedicines. 2022. PMID: 36140337 Free PMC article. Review.
• Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis.
  Akitake R, Nakase H, Tamaoki M, Ueno S, Mikami S, Chiba T. Akitake R, et al. Dig Dis Sci. 2010 Jun;55(6):1781-4. doi: 10.1007/s10620-009-0910-5. Epub 2009 Aug 12. Dig Dis Sci. 2010. PMID: 19672713 No abstract available.
• Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report.
  Caviglia GP, Tucci A, Pellicano R, Fagoonee S, Rosso C, Abate ML, Olivero A, Armandi A, Vanni E, Saracco GM, Bugianesi E, Astegiano M, Ribaldone DG. Caviglia GP, et al. J Clin Med. 2020 Jul 23;9(8):2353. doi: 10.3390/jcm9082353. J Clin Med. 2020. PMID: 32717980 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information